Related Experiment Video

Updated: Jan 3, 2026

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay
06:07

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay

Published on: June 7, 2020

5.2K

Scanning for clues to better use selective estrogen receptor modulators

Mitchell J Machiela1, Stephen J Chanock

  • 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, MD 20877, USA.

Cancer Discovery
|July 13, 2013
PubMed

Insights

Researchers identified genetic variants linked to selective estrogen receptor modulator (SERM) therapy response. These findings may advance personalized breast cancer prevention by clarifying BRCA1 gene expression in high-risk women.

Area of Science:

  • Oncology
  • Genetics
  • Pharmacogenomics

Background:

  • Selective estrogen receptor modulators (SERMs) are crucial in breast cancer prevention and treatment.
  • Understanding individual response to SERMs is key for effective, personalized medicine.
  • Estrogen signaling pathways, including BRCA1 expression, play a significant role in breast cancer development.

Purpose of the Study:

  • To identify genetic variants associated with patient response to SERM therapy.
  • To explore the connection between these genetic variants, estrogen-dependent BRCA1 expression, and breast cancer risk.
  • To lay the groundwork for individualized preventive strategies in high-risk women.

Main Methods:

  • The study involved analyzing genetic data from patients undergoing SERM therapy.
  • Correlations between specific genetic variants and treatment response were assessed.
  • Further investigations explored the impact on BRCA1 gene expression.

Main Results:

  • Key genetic variants influencing response to SERM therapy were identified.
  • A potential link between these variants and estrogen-mediated BRCA1 induction was suggested.
  • These findings highlight the genetic underpinnings of SERM efficacy.

Conclusions:

  • The identified genetic variants may predict response to SERM therapy.
  • Substantiation of these findings could significantly advance the understanding of BRCA1 regulation.
  • This research represents a step towards personalized breast cancer prevention strategies for high-risk individuals.

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.7K
Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

10.9K

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.3K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K